127 related articles for article (PubMed ID: 7056168)
1. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
[TBL] [Abstract][Full Text] [Related]
2. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
Claycomb CL; Berkovic M
J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
[No Abstract] [Full Text] [Related]
3. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
Hayano K; Fukui H; Otsuka Y; Hattori S
Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
[No Abstract] [Full Text] [Related]
4. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
[TBL] [Abstract][Full Text] [Related]
5. Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.
Bruntsch U; Groos G; Tigges FJ; Gallmeier WM
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):905-9. PubMed ID: 6540191
[TBL] [Abstract][Full Text] [Related]
6. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
Grem JL; Merritt JA; Carbone PP
Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
[TBL] [Abstract][Full Text] [Related]
7. [Thrombotic microangiopathy and chronic renal failure caused by mitomycin C in 4 women treated for breast cancer].
Bayle F; Vialtel P; Bastrenta F; Swiercz P; Dechelette E; Pin I; Carpentier P; Mousseau M; Schaerer R; Couderc P; Cordonnier D
Nouv Presse Med; 1982 Jun; 11(30):2300-1. PubMed ID: 6810311
[No Abstract] [Full Text] [Related]
8. [Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
Ito S; Hirono S
Rinsho Ketsueki; 1982 May; 23(5):730-5. PubMed ID: 6813535
[No Abstract] [Full Text] [Related]
9. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
[TBL] [Abstract][Full Text] [Related]
10. Reversible microangiopathic hemolytic anemia after mitomycin C.
Perry DJ
Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
[No Abstract] [Full Text] [Related]
11. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
[TBL] [Abstract][Full Text] [Related]
12. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
[TBL] [Abstract][Full Text] [Related]
13. Silent renal microangiography after mitomycin C therapy.
Poch E; González-Clemente JM; Torras A; Darnell A; Botey A; Revert L
Am J Nephrol; 1990; 10(6):514-7. PubMed ID: 2127509
[TBL] [Abstract][Full Text] [Related]
14. [Microangiopathic hemolytic anemia associated with mitomycin-C treatment].
Godes M; Camps C; Martínez A
An Med Interna; 1991 Dec; 8(12):611-3. PubMed ID: 1782316
[TBL] [Abstract][Full Text] [Related]
15. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
Meguro S; Nagata T; Yokoyama K; Chinen T; Kobayashi T; Yamazaki H; Kuraishi Y; Ichiba ; Abe M; Isogai Y
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
McCarthy JT; Staats BA
Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
[TBL] [Abstract][Full Text] [Related]
17. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Sheldon R; Slaughter D
Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Chauvergne J; Durand M; Brunet R; Bui BN; Hoerni B; Mauriac L
Bull Cancer; 1981; 68(5):442-8. PubMed ID: 6800426
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
Nishi I; Yokoyama T; Nakao I; Harashima S; Ohashi Y; Kanko T; Saito T
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Waldhorn RE; Tsou E; Smith FP; Kerwin DM
Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
